ASTA Corporation (246720.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
6,070.00 KRW
Market cap
99.43 bn KRW
P/E (2025)
–
P/S (2025)
38.32
Dividend yield
0.00 %
Net margin
-127.31 %
Return on equity (ROE)
-35.81 %
Return on assets (ROA)
-21.33 %

ASTA Corporation financials

Fiscal year20242025
Revenue3.35 bn KRW2.59 bn KRW
Gross profit957.86 m KRW1.26 bn KRW
Operating income-4.02 bn KRW-2.59 bn KRW
EBIT-3.66 bn KRW-2.98 bn KRW
Net income-3.86 bn KRW-3.30 bn KRW
Diluted EPS – continuing operations-284.79 KRW-201.66 KRW

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ASTA Corporation

ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also provides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such as cancer and degenerative brain diseases; LDI-TOF, an laser desorption ionization time of flight mass spectrometer for OLED analysis and test; MALDI Plate, a disposable plate; and rapid enzyme digestion system. In addition, the company provides diagnostics software. ASTA Corporation was founded in 2006 and is based in Suwon-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 24.03.2026. Details in the risk notice.